“Acquired CD20 Loss As a Mechanism of Resistance to Mosunetuzumab in Relapsed Follicular Lymphoma ”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 18, no. 1, Jan. 2026, p. e2026014, https://doi.org/10.4084/MJHID.2026.014.